Multiple Drug Abuse Involving Nonopiate, Nonalcoholic Substances. II. Physical Damage, Long-Term Psychological Effects and Treatment Approaches and Success

References

• Acord L. D. Hallucinogenic drugs and brain damage. Mil. Med 1972; 137: 18–19
   PubMed Web of Science ®Google Scholar
• Acord L. D., Barker D. D. Hallucinogenic drugs and cerebral deficit. J. Nerv. Ment. Dis 1973; 156: 281–283
   PubMedGoogle Scholar
• Adams K. M., Rennick P. M., Schoof K. G., Keegan J. F. Neuropsychological measurement of drug effects: Polydrug research. J. Psychedelic Drugs 1975; 7: 151–160
   Web of Science ®Google Scholar
• Anderson W. H., O'Malley J. E., Lazare A. Failure of outpatient treatment of drug abuse. II. Amphetamines, barbiturates, hallucinogens. Am. J. Psychiatry 1972; 128: 1572–1576
   PubMedGoogle Scholar
• Avery R. F., Judd L. L., Riney W., Takahashi K. Long-term follow-up on a multiple drug abusing population using a multi-level assessment approach. Drug Abuse: Modern Trends, Issues and Perspectives, A. Schecter, H. Alksne, E. Kaufman. Dekker, New York 1978; 686–695
   Google Scholar
• Babst D. V., Chambers C. D., Warner A. Patient characteristics associated with retention in a methadone maintenance program. Br. J. Addict 1971; 66: 195–204
   Google Scholar
• Baaron S. P., Lowinger P., Ebner E. A clinical examination of chronic LSD use in the community. Compr. Psychiatry 1970; 11: 69–79
   PubMedGoogle Scholar
• Bowers M. B. Acute psychosis induced by psychotomimetic drug abuse. Arch. Gen. Psychiatry 1972; 27: 437–440
   PubMed Web of Science ®Google Scholar
• Breakey W. R., Goodell H., Lorenz P. C., McHugh P. R. Hallucinogenic drugs as precipitants of schizophrenia. Psychol. Med 1974; 4: 255–261
   PubMed Web of Science ®Google Scholar
• Brown C. Hallucinogenic Drugs. Thomas, Springfield, Illinois 1972
   Google Scholar
• Bruhn P., Maage N. Intellectual and neuropsychological functions in young men with heavy and long-term patterns of drug abuse. Am. J. Psychiatry 1975; 132: 397–401
   PubMed Web of Science ®Google Scholar
• Chambers C. D., Brill L. Some considerations for the treatment of nonnarcotic drug abusers. Ind. Med. Surg 1971; 40: 29–38
   Google Scholar
• Citron B. P., Halpern M., McCarron M., Lundberg G. D., McCormick R., Pincus I. J., Tatter D., Haverback B. J. Necrotizing angiitis associated with drug abuse. N. Engl. J. Med 1970; 283: 1003–1011
   PubMed Web of Science ®Google Scholar
• Cohen S., Edwards A. E. LSD and organic brain impairment. Drug Depend 1969; 2: 1–4
   Google Scholar
• Connell P. H. Amphetamine Psychosis. Chapman and Hall, LondonEngland 1958
   Google Scholar
• Connell P. H. Some observations concerning amphetamine misuse: Its diagnosis, management, and treatment with special reference to research needs, Drugs and Youth. Proceedings of the Rutgers Symposium on Drug Abuse, J. R. Wittenborn, H. Brill, J. P. Smith, S. A. Wittenborn. Thomas, Springfield, Illinois 1969; 125–134
   Google Scholar
• Culver C. M., King F. W. Neuropsychological assessment of undergraduate marijuana and LSD users. Arch. Gen. Psychiatry 1974; 31: 707–711
   PubMed Web of Science ®Google Scholar
• Ellinwood E. H. Amphetamine and cocaine. Psychopharmacology in the Practice of Medicine, M. E. Jarvik. Appleton-Century-Crofts, New York 1977; 467–479
   Google Scholar
• Ellinwood E. H., Petrie W. M. Psychiatric syndromes induced by non-medical use of drugs. Research Advances in Alcohol and Drug Problems, R. J. Gibbins. Wiley, New York 1976; Vol. III: 177–221
   Google Scholar
• Evans M. Cerebral disorders due to drugs of dependence and hallucinogens. Alcohol, Drugs and Brain Damage, J. G. Rankin. Addiction Research Foundation of Ontario, TorontoCanada 1975; 21–42
   Google Scholar
• Frosch W. Patterns of response to self administration of LSD. Adverse Reactions to Hallucinogenic Drugs, R. E. Meyer. U.S. Government Printing Office, Washington, D.C. 1969; 74–79, National Institute of Mental Health, Public Health Services Publication No. 1810
   Google Scholar
• Frosch W. A., Robbins E. S., Stern M. Untoward reactions to lysergic acid diethylamide (LSD) resulting in hospitalization. N. Engl. J. Med 1965; 273: 1235–1239
   PubMed Web of Science ®Google Scholar
• Gearing F. R. Evaluation of methadone maintenance treatment program. Methadone Maintenance, S. Einstein. Dekker, New York 1971; 171–197
   Google Scholar
• Glass G. S., Bowers M. B. Chronic psychosis associated with long-term psychotomimetic drug abuse. Arch. Gen. Psychiatry 1970; 23: 97–103
   PubMedGoogle Scholar
• Goodwin D. W., Hill S. Y. Chronic effects of alcohol and other psychoactive drugs on intellect, learning and memory. Alcohol, Drugs and Brain Damage, J. G. Rankin. Addiction Research Foundation of Ontario, TorontoCanada 1975; 55–69
   Google Scholar
• Grant I., Adams K. M., Carlin A. S., Rennick P. M. Neuropsychological deficit in polydrug users. Drug Alcohol Depend 1977; 2: 91–108
   PubMed Web of Science ®Google Scholar
• Grant I., Adams K. M., Carlin A. S., Rennick P. M., Judd L. L., Schoof K., Reed R. Organic impairment in polydrug users: Risk factors. Am. J. Psychiatry 1978; 135: 178–184
   PubMed Web of Science ®Google Scholar
• Grant I., Judd L. L. Neuropsychological and EEG disturbances in polydrug users. Am. J. Psychiatry 1976; 133: 1039–1042
   PubMed Web of Science ®Google Scholar
• Grant I., Mohns L. Chronic cerebral effects of alcohol and drug abuse. Int. J. Addict 1975; 10: 883–920
   PubMedGoogle Scholar
• Hekimian L. J., Gershon S. Characteristics of drug abusers admitted to a psychiatric hospital. J. Am. Med. Assoc 1968; 205: 125–130
   PubMed Web of Science ®Google Scholar
• Hubbard B., Judd L. L., Avery R. Pharmacotherapy of drug abusers: Adjunctive psychopharmacologic management of nonopiate mixed substance abusers in an outpatient setting. Int. J. Addict 1978; 13: 383–393
   PubMed Web of Science ®Google Scholar
• Jaffe J. Drug addiction and drug abuse. The Pharmacological Basis of Therapeutics, 5th ed., L. S. Goodman, A. Gilman. Macmillan, New York 1975; 284–324
   Google Scholar
• Judd L. L., Grant I. Brain dysfunction in chronic sedative users. J. Psychedelic Drugs 1975; 7: 143–149
   Web of Science ®Google Scholar
• Kalant O. J. The Amphetamines: Toxicity and Addiction, 2nd ed. University of Toronto Press, TorontoCanada 1973
   Google Scholar
• Kaufman E. The abuse of multiple drugs. II. Psychological hypotheses, treatment considerations. Am. J. Drug Alcohol Abuse 1976; 3: 293–301
   PubMed Web of Science ®Google Scholar
• Kornblith A. B. Multiple drug abuse involving nonopiate, nonalcoholic substances. I. Prevalence. Int. J. Addict 1981; 16: 197–232
   PubMed Web of Science ®Google Scholar
• Kramer J. C. Some observations on and a review of the effects of high-dose use of amphetamines. Drug Abuse: Proceedings of the International Conference, Philadelphia, Pennsylvania, 1972, C. J.D. Zarafonetix. Lea and Febiger, 253–261
   Google Scholar
• Lezak M. D. Neuropsychological Assessment. Oxford University Press, New York 1976
   Google Scholar
• Lipski J., Stimmel B., Donaso E. The effect of heroin and multiple drug abuse. Am. Heart J 1973; 86: 663–668
   PubMed Web of Science ®Google Scholar
• McGlothlin W. H., Arnold D. Q., Freedman D. X. Organicity measures following repeated LSD ingestion. Arch. Gen. Psychiatry 1969; 21: 704–709
   PubMed Web of Science ®Google Scholar
• McKenna G. J., Fisch A., Levine M. E., Patch V. D., Raynes A. E. Problems of mixed addictions on a detoxification unit. Fifth National Conference on Methadone Treatment: 1973 Proceedings. National Association for the Prevention of Addiction to Narcotics, New York 1973; Vol. II: 990–994
   Google Scholar
• Patch V. D., Cohen M., Howe L. P., Raynes A. E. The efficacy of detoxification as a treatment modality for polydrug abusers. Drug Abuse: Modern Trends, Issues and Perspectives, A. Schecter, H. Alksne, E. Kaufman. Dekker, New York 1978; 316–329
   Google Scholar
• Podell M., Trilling F. G., Angle H. V., Moore E. K. Treatment referral of the polydrug abuser. Drug Abuse: Modern Trends, Issues and Perspectives, A. Schecter, H. Alksne, E. Kaufman. Dekker, New York 1978; 142–148
   Google Scholar
• Roizin L., Halpern M., Baden M. M., Kaufman M., Hashimoto S., Liu J. C., Eisenberg B. Neuropathology of drugs and dependence. Chemical and Biological Aspects of Drug Dependence, S. J. Mul, H. Ébrill. Chemical Rubber Co., Cleveland, Ohio 1972; 389–411
   Google Scholar
• Rosenthal S. H. Persistent hallucinosis following repeated administration of hallucinogenic drugs. Am. J. Psychiatry 1964; 121: 238–244
   PubMed Web of Science ®Google Scholar
• Rumbaugh C. L., Bergeron R. T., Fang H. C.H., McCormick R. Cerebral angiographic changes in the drug abuse patient. Radiology 1971; 101: 335–344
   PubMed Web of Science ®Google Scholar
• Sanborn B., Daniels J. LSD reactions: A family research approach. Int. J. Addict 1971; 6: 497–507
   Web of Science ®Google Scholar
• Tatetsu S. Methamphetamine psychosis. Folia Psychiatr. Neurol. Jpn., Suppl 1963; 7: 337–380
   Google Scholar
• Tennant F. S., La Brosse C. R. Outpatient Treatment and Outcome of Non-Heroin, Non Alcohol Drug Problems. U.C.L.A. School of Public Health. 1978, Unpublished manuscript
   Google Scholar
• Ungerleider J. T., Fisher D. D., Fuller M. The dangers of LSD. J. Am. Med. Assoc 1966; 197: 389–392
   PubMed Web of Science ®Google Scholar
• Ungerleider J. T., Fisher D. D., Fuller M., Caldwell A. The “bad trip”-The etiology of the adverse LSD reactions. Am. J. Psychiatry 1968; 124: 88–94
   Google Scholar
• Wesson D. R., Smith D. E., Lerner S. E., Kettner V. R. Treatment of polydrug users in San Francisco. Am. J. Drug Alcohol Abuse 1974; 1: 159–179
   PubMed Web of Science ®Google Scholar
• Wright M., Hogan T. P. Repeated LSD ingestion and performance on neuropsychological tests. J. Nerv. Ment. Dis 1972; 154: 432–438
   PubMed Web of Science ®Google Scholar
• Yatsu F. M., Wesson D. R., Smith D. E. Amphetamine abuse. Medical Aspects of Drug Abuse, R. W. Richter. Harper and Row, New York 1975; 50–56
   Google Scholar